Bausch & Lomb Corp (BLCO) stock: key figures, P/E, revenue and dividend
Industrials · Canada · ISIN CA07174N1090
Bausch & Lomb Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 5.10 bn USD |
| Operating income | 113.00 m USD |
| EBIT | 92.00 m USD |
| Net income | -360.00 m USD |
| Diluted EPS – continuing operations | -1.02 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bausch & Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
More stocks
- RHYTHM PHARMACEUTICALS, INC. (RYTM)
- Mineral Resources Ltd (MIN.AX)
- Dolby Laboratories, Inc. (DLB)
- Gan & Lee Pharmaceuticals Co Ltd (603087.SS)
- Telefonica Deutschland Holding (O2D.HM)
- ADT Inc. (ADT)
- Zheshang Securities Co Ltd (601878.SS)
- BLUE OWL CAPITAL INC. (OWL)
- TEREX CORP (TEX)
- TIS Inc (3626.T)
- Whitbread PLC (WTB.L)
- DKSH Holding AG (DKSH.SW)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.